The relationship between expression of the c-erbB-2 protooncogene and the biology of breast cancer has been investigated widely, most studies using immunohistochemistry in formalin-fted, padlibembedded tissueS. This technique is at best semiquantitative and there is a high degree of interstudy variability because of its subjective nature and poor methodological standardization. The relationship between the levels of expression and biology can be examined thoroughly only with an accurately quantitative technique. We have developed a radioimmunohistochemical assay to measure ~1 8 5 e h * -~ in tissue biopsy specimens. The method involves incubating frozen sections with 125I-labeled monoclonal antibody, microautoradiograpy, and grain counting with image analysis. Seaions of cell pellets with known c-erbB-2 levels are processed with each batch of samples as internal calibration standards. We have quantified c-erbB-2
Introduction
p185erbB-2 is expressed at high levels in approximately 20% of human breast cancers, and patients with tumors overexpressing this molecule have a poor prognosis (reviewed by Ravdin and Chamness, 1995; Gullick, 1990) . A functional role for c-erbB-2 during the development and progression of breast cancer has been hypothesized, which has led to the current interest in targeting this receptor for therapeutic purposes. Most studies examining c-erbB-2 expression in breast cancer have employed immunohistochemical analysis of formalin-fixed, paraffin-em bedded tissues. This type of assay suffers from a number of limitations and may not be sufficiently accurate to thoroughly assess the relationship between the levels of c-erbB-2 expression and the biology of breast cancer. First, routinely processed material may be fixed for times ranging from ' Supported by the Medical Research Council, the Cancer Research Campaign and the Scottish Hospitals' Endowments Research Trust.
Correspondence to: Jonathan R. Reeves, PhD. Univ. Department of Surgery, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, United Kingdom. expression in 60 breast carcinomas and compared the results with conventional immunohistochemistry. Radioimmunohistochemistry measured receptor levels throughout the range of expression in breast carcinomas, whereas conventional immunohistochemistry detected the protein only in the highest expressing tumors. The quantitative, objective data produced by radioimmunohistochemistry allow a mote thorough evaluation of the relationship between c-erbB-2 expression and tumor biology. This technique may have applications in other fields where quantitative data is required and relevant mono-dona1 antibodies are available. ( J Hisrochem C y r d e m KEY WORDS: Immunohistochemistry; Immunocytochemistry; Autoradiography; Breast cancer; c-erbB-2; Her2INeu; Monoclonal antibody; Quantitative; radioimmunohistochemistry; Radioimmunocytochemistry.
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a few hours to over a weekend, which is likely to result in variable antigenicity, and tissue in the center of a large block will have a lesser degree of fixation compared to tissue on the periphery, which may explain the variation in staining commonly seen across an individual section. Second, the many methods for amplifying the signal generated by binding of the primary antibody result in a range of sensitivities. Finally, methods for scoring immunohistochemical sections are subjective, with a high degree of interobserver variability. Together, these factors are likely to lead to significant interstudy variation and may account for the wide range of values (9-39%) for the proportion of breast tumors reported to overexpress c-erbB-2 (reviewed by Gullick, 1990) . The need for a high level of concordance among different laboratories and assay procedures when studying tumor markers has been well-voiced (Ravdin and Chamness, 1995; Koenders et al., 1992) . Western blot and ELISA-based assay systems that quantitate receptors in tissue extracts have been described (Nugent et al., 1992) , but breast tumors are made up from variable proportions of tumor and nontumor cells, and, in some diffuse cases, an extract will be derived predominantly from nonmalignant cells. Assays based on tissue homogenates therefore give average receptor estimations from a range of cell types.
We have developed a quantitative radioimmunohistochemical method for the measurement of in frozen tissue sections that circumvents many of the problems associated with conventional assays. Radioimmunohistochemistry is quantitative over the range of c-erbB-2 expression in the majority of breast tumors, the assay yields objective data, and a series of internal calibration standards for each batch of tumors ensures consistency among assays. Radioimmunohistochemistry gives information over and above the data obtained by conventional immunohistochemical methods and can be a more appropriate tool for the analysis of c-erbB-2 expression in relation to the biology of breast cancer. This article describes the development and characterization of radioimmunohistochemistry and its direct comparison with conventional immunohistochemistry for analysis of p185erbB-2 in a series of 60 breast carcinomas.
Materials and Methods

Tumors
Tissue from 60 patients undergoing surgery for primary breast cancer in Glasgow Royal Infirmary between 1984 and 1994 was used for the study. Fresh specimens were frozen in liquid nitrogen, with the remainder being fixed in formalin and processed to wax. Frozen tissue was stored at -70°C or in liquid nitrogen.
Antibodies and Immunohistochemical ReagentJ
The ICRl2 rat IgG2, monoclonal antibody (a gift from Dr. C. Dean, Institute of Cancer Research, Sutton, London) was raised to the external domain of the c-erbB-2 protein of BT474 cells (Styles et al., 1990) . Dako (High Wycombe. UK) anti-c-erbB-2 oncoprotein and 21N (Gullick et al., 1987) polyclonal antibodies were raised in rabbits to different synthetic peptides homologous to regions within the internal domain of the human c-erbB-2 protein. Affinity-purified 21N was provided by Prof. W. Gullick. All other antibodies were purchased from Dako. The streptavidin-biotin-peroxidase complex (sABC) was prepared as for the avidin-biotin-peroxidase complex described by Hsu (Hsu et al., 1981) , except that N-biotinyl-Eaminocaproic acid N-hydroxvsuccinimide ester, incorporating a spacer arm, was used as the biotinylating reagent.
Characterization of CeZZ Line Standards
Tissue Culture. Seven cell lines were characterized as Cali bration standards for the radioimmunohistochemical assay. MCF-7. ZR75-1, and N87 were grown in RPMl and MDA-MB-361, MDA-MB-453, SKBR3. and BT474 cells were maintained in DMEM. Both media were supplemented with 10% fetal bovine serum and the cells were cultured in a 95% air, 5% CO2 atmosphere at 37°C. These cell lines are available from the American Type Cell Culture Collection (Rockville, MD). Cells were grown to near confluence in 175-cm2 flasks, harvested by scraping and centrifugation at 100 x g, and resuspended in 10 ml of PBS (10 mM sodium phosphate, 140 mM NaCI, pH 7.4). Small aliquots were removed for counting before being stored frozen for later use as standards for estimating the protein content and cell numbers within the sections (see below). The remainder of the cells were then pelleted at 300 x g, the supernatant was removed, and the pellets were frozen by plunging the centrifuge tubes into liquid nitrogen. Pellets were detached by giving the tube a sharp blow before being stored in liquid nitrogen.
Additional cells were fixed in formalin and embedded in wax. Cells were grown and harvested as described above, but they were resuspended in 4% formaldehyde in PBS and fixed overnight. After centrifugation at 500 x g for 10 min, the fixative was removed before the cells were washed twice in distilled water. To enable manipulation of the pellets, the cells were immersed in 5 ml of fresh distilled water containing a few drops of 1% aqueous eosin. After a single wash in distilled water the cell pellet was resuspended in 1% agarose at 60'C. The agarose was changed twice over a 90-min period before the agarose plug was allowed to solidify at 4°C. The agarose plug containing the cell pellet was then processed to wax using conventional procedures.
Binding Analysis with Sections of Cell Pellets. Frozen cell pellets were mounted on cryostat chucks and trimmed down so that multiple IO-pm sections of similar cross-sectional area could be cut. These were thawed onto silanized microscope slides, dried, and sealed with airtight packaging and stored at -70°C until use. The ICRl2 antibody was labeled with Iz51 by the iodogen method (detailed in Harlow and Lane, 1988) . Briefly, 15 fig of antibody was incubated with 10 MBq of '"1 for 5 min in the presence of 50 fig of iodogen in a total of 125 pl of PBS, resulting in about 50% incorporation. The reaction was terminated by addition of 875 pl of 50% rabbit serum in PBS. The free iodine was removed by gel filtration (Sephadex (3-25) and the labeled antibody was stored frozen in aliquots and used within 2 weeks. The slides were warmed to room temperature (RT) before the airtight packaging was removed and were randomized to distribute evenly any systematic error due to sectioning through the pellet. Each section was rehydrated with a 5O-pl drop of 20% rabbit serum in PBS and left for 10 min. Radiolabeled antibody was added to give a total volume of 100 or 200 pllsection, with eight final concentrations of antibody ranging from 2 pM to 5 nM with six replicate sections at each concentration. The final antibody concentrations were diluted in PBS containing rabbit serum at 20%. Nonspecific binding was determined with a 200-fold excess of unlabeled antibody. Incubation was continued in humidified chambers at 22°C to binding equilibrium (predetermined to be less than 4 hr at this temperature) and was terminated by three 20-sec washes in PBS. After the final wash, the sections were dried, solubilized in 0.5% SDS, and transferred into y-counting vials for measurement of the bound iodinated antibody. Each cell line was assayed at least three times using separate pellets, and binding data were assessed by nonlinear least-squares regression analysis with the LIGAND program (Munson and Rodbard, 1980) to derive the total number of sites available for antibody binding in the sections and the error associated with each estimate (coefficient of variation). The areas of eight sections from each binding assay were measured using an Imaging Research (St. Catherines, Ontario, Canada) image analysis system. These sections were then dissolved in 0.5 M NaOH and the protein content measured using the Bio-Rad reagents (Bradford, 1976) against bovine serum albumin and known cell concentration standards (see above). Therefore, for each binding assay, mean section area, protein content, and cell number were estimated.
Dot-blots and Western Blots. Each of the seven cell lines was grown to near confluence in 80-cm2 flasks. The medium was removed and the cells were washed in two changes of ice-cold PBS before being dissolved in 600 p1 of lysis buffer (50 mM Hepes, pH 7.4, loh Triton X-100, 150 mM NaCI, 5 mM EGTA, 100 Nglml PMSF, 10 pglml aprotinin, 100 pg/ml benzamidine, 5 pglml leupeptin, and 100 pM Na3V04). The cells were harvested with a scraper and after gentle agitation at 4'C for 20 min the particulate fraction was removed by centrifugation at 15,000 x g for 10 min. The supernatant was stored frozen in aliquots at -70'C. The protein concentrations in the lysates were measured using the Bio-Rad protein estimation reagent (Bradford, 1976) . The lysates were denatured by boiling for 4 min in Laemmli buffer (0.125 M Tris-HCI, pH 6.7, 2 O h SDS, 10% glycerol. 2.5% mercaptoethanol). For the dot-blots, a range of concentrations ofdenatured lysate were transferred to PVDF membranes (Amersham Hybond; Poole, UK) using a vacuum blotting apparatus according to the manufacturer's recommendations (Stratagene; Cambridge, UK). For the Western blots, 100 pgMCF7, 50 pgZR75-1,20 pg MDA-MB-453, 10 pg MDA-MB-361,5 pg BT474 and SKBR3, and 2 pg ofN87 denatured lysates were resolved by 7.5 % polyacrylamide gel electrophoresis under reducing conditions including prestained molecular weight markers. The proteins were transferred to PVDF membranes using a semidry blotting apparatus (Bio-Rad Laboratories: Hemel Hempstead, UK). After transfer, the PVDF membranes were blocked in TTBS (10 mM Tris-HC1, pH 7.4, 150 mM NaCI, 0.05% Tween 20) containing 5% dried skimmed milk and 2 % swine serum overnight at RT. The membranes were then incubated with 21N or the Dako anti c-erbB-2 primary antibody at concentration of 1 pg/ml in blocker for 2 hr. After three 10-min washes in TTBS. the membranes were incubated with the peroxidase-linked secondary antibody (1:5000) diluted in blocker.
After further washes in TTBS, the immunoreactive proteins were detected by enhanced chemiluminescence according to the manufacturer's instructions (Amersham International PIC.; Amersham, UK).
Radioimmunohistochemistry of Cell Lines and Tumors
Labeling of Sections. Cryostat sections (5 pm) were fixed in 100% acetone for 10 min and nonspecific binding was minimized by incubating the sections with 100 pl of 50% rabbit serum. After 20 min, 10 pl of radiolabeled ICRl2 antibody (diluted with unlabeled antibody to contain a total of 50 ng of antibody and 1 KBq of ">I) was added to each drop and the sections were incubated for 3 hr in a humidified chamber at 22'C. Duplicate test sections and a single control section (incubated in the presence of a 100-fold excess of unlabeled antibody) were processed for each tumor. After incubation, unbound antibody was removed by three 5-min washes in PBS and the bound antibody molecules were crosslinked to the receptors by fixation with 2% formaldehyde in PBS. The sections were washed through three changes of distilled water and allowed to air-dry.
Autoradiography. The sections were secured in an X-ray cassette and overlaid with X-ray film, which was exposed for about 72 hr. This film was used as a guide to the necessary length of exposure for the final stage of the preparation, in which the slides were dipped in autoradiographic emulsion (Kodak NTB-2 diluted 1:1 with distilled water at 43T). After air-drying, exposure was carried out at 4'C in the presence of silica gel as dehumidifier, with the highly expressing tumors and cell lines being exposed for 4 hr, the intermediate tissues for 24 and 48 hr, and the weakly expressing specimens for 4 days. The correct exposure results in single silver grains, and overexposed sections where the grains were fusing were not used. The emulsion was developed with Kodak D 19 developer (1:l in distilled water) at 10°C for 4 min, and the slides were rinsed in distilled water and then fixed in Kodak Unifix fixer for 5 min. After 20-min washing through four changes of distilled water, the sections were counterstained lightly with safranin and dehydrated and mounted through standard solutions.
Image Analysis. A Joyce-Loebl MiniMagiScan image analysis system connected to an Olympus OM-2 microscope via a monochrome video camera was used for estimation of silver grain density. Areas of invasive tumor within the sections were identified by the operator, and the grains within these areas were counted by the system. The safranin counterstain was filtered out with a red filter before the threshold was set by the operator to allow binary segmentation of the grains from the background. The number of single grains within the areas of interest were counted with the system's counting algorithm. Full or partial fields were counted using a x 40 objective, and 10 such fields taken from different regions of the section were summed for each slide. The seven cell line pellet calibration standards were included with each batch of tumor sections. Results were expressed as grains per unit area per hour of emulsion exposure after subtraction of the counts for the negative control slides.
Calculation of Receptor Density in Tumors. For each cell line, the ratio of the known receptor density (from the binding analysis experiments) to the radioimmunohistochemically derived grain density pcr hour of emulsion exposure was calculated. The mean of these ratios was used as a factor to convert the tumor grain counts to c-er6B-2 receptor densities. In this way, equal weighting was given to each ofthe standards, whereas a regressionbased approach would have given greater weighting to the cell lines with the higher receptor levels. Two of the cell lines were not used for this estimation. N87s were beyond the linear range of the technique and MCF7s did not have sufficient receptors to produce significant grain counts under the conditions of the assay. Few tumors were within the MCF-7 range, but a number had receptor densities between the SKBR-3 and N87 standards. The receptor levels of these tumors were estimated in a manner similar to that used for the lower-expressing tissues, with the knowledge that the calculated value was possibly an underestimate of the true receptor density.
Conventional Immunohistochemistry
Immunohistochemistry was performed in humidified chambers at 22'C and the sections were washed through three 5-min changes of pBS (pH 7.4) between each step. The serum blocking solution for immunohistochemistry with the rat monoclonal primary antibody contained 25% human serum and 25% rabbit serum in PBS. with the primary and secondary antibody solutions containing 10% of each xrum type. For immunohistochemistry with the rabbit polyclonal primary antibody, blocking sera were used similarly but swine serum was used in the place ofrabbit serum.
Frozen Secrions. Frozen sections (5 pm) were cut and thawed onto silanized slides, stored at -70'C in airtight packaging, and allowed to warin to RT before opening. The sections were fixed in 100% acetone and washed in PBS. Endogenous biotin was suppressed by incubating the sections with 50% egg white for 30 min . Further nonspecific binding was inhibited with the serum blocking solution (10 min), which was then aspirated off and replaced with the rat monoclonal anti-c-er6B-2 antibody at a concentration of 1 pg/ml, supplemented with 0.02% free biotin. After 2 hr the sections were washed and incubated for 30 min with biotinylated anti-rat immunoglobulins at a 1:400 dilution. This was then replaced with the sABC reagent for a further 30-min incubation. Afterwashing, the peroxidase signal was developed with a 10-min exposure to 0.07% NiC12.6H20, 0.025% diaminobenzidine tetrahydrochloride, and 0.01% H202, producing a black precipitate. The nuclei were counterstained red with safranin before dehydration and mounting through standard solutions. Parallel control sections were processed similarly, with the rat monoclonal antibody being replaced with nonimmune rat IgG2, at a concentration of 1 pg/ml. Paraffin Sections. Sections were cut at 5 pm and mounted on silanized slides. After clearing and rehydration through standard solutions, endogenous peroxidase was suppressed with 3% H202 in PBS for 10 min. The sections were incubated for 10 min with blocking serum, which was then aspirated off and replaced with the polyclonal anti-c-er6B-2 antibody (Dako) at a dilution of 1:400. After a 2-hr incubation, the primary antibody was replaced with the appropriate biotinylated secondary antibody for 30 min, which in turn was replaced with the sABC complex for a further 30 min. After washing, the peroxidase signal was developed with a 10-min exposure to 0.05% diaminobenzidine tetrahydrochloride and 0.01% H202. The sections were counterstained lightly with hematoxylin before dehydration and mounting through standard solutions. Parallel control sections were prepared for each specimen by using nonimmune rabbit IgG in the place of the primary antibody.
Immunohistochemical Scoring. The percentage of tumor cells falling into negative, weakly positive, moderately positive, and strongly positive categories was qualitatively assessed. The sum of (1 x % weakly positive) + (2 x o h moderately positive) + (3 x % strongly positive) was used as a histoscore, with a maximum of 300. BT474s, which is in accordance with the binding experiment results expressed as receptors per pg protein rather than receptors per unit area. The Western blots confirmed that the vast majority of the immunoreactive material in the dot-blots localized to a single band at around 185 KD (Figure 1B) .
Radioimmunohistochemistry. There was a linear relationship
Results
Characterization of CeL Line Standard
These experiments were designed to measure accurately p185erbB-2 levels in a panel of cell lines which could then be used as calibration controls for radioimmunohistochemistry. Binding analysis using the ICRl2 monoclonal antibody labeled with 12sI was used to measure the receptor density in sections of the cell pellets. In addition, two polyclonal antibodies were used in a semiquantitative dot-blot assay on lysates of the cell lines to confirm that the relative ratios of p185erbB-2 were as expected from the binding analysis. The molecular weight of the immunoreactive material in the dot-blots was confirmed by Western blotting.
Binding Analysis on Sections. Nonspecific binding in the presence of an excess of unlabeled antibody was less than 1% of the total binding in all cell lines. Nonlinear least-squares regression analysis indicated that there was no significant evidence that the binding data could be better described by anything more complex than a one-ligand, one binding-site model resulting in linear Scatchard plots. However, there was a significant decrease in the binding affinity with the N87 cells. The association constant derived from pooled data for the other six cell lines was 2.56 x 109 M-l (coefficient of variation of 12%), with a dissociation constant of 3.9 x M, and for the N87 cells was 2.94 x lo8 M-' (coefficient of variation of 33%), with a dissociation constant of 3.4 x 10-9 M. This difference was statistically significant (p<O.OOO~) using a t-test on logarithmically transformed data. The calculated maximal binding capacity of the antibody or estimated receptor densities derived for the seven cell lines are presented in Table 1 .
Dot-blots and Western Blots. Both polyclonal antibodies gave similar results. The dot-blots ( Figure 1A) indicate that the relative amounts of immunoreactive material were in the proportions expected from the binding experiments. N87 cells had a higher level than the other cell lines, but not to the extent expected from the binding experiments. SKBR3 cells produced a weaker signal than between the receptor quantification by binding analysis and radioimmunohistochemistry for five cell lines (ZR75-1, MDA-MB-453, MDA-MB-361, BT474, and SKBR3), with a correlation coefficient of 0.98 @=0.004) (Figure 2 ). However, with the highest receptor levels there was loss of linearity, with N87 cells having seven times as many sites as SKBR3 by binding analysis and only 2.5-fold higher levels by radioimmunohistochemistry. MCF-7 cells did not register a grain count that was significantly different from the controls under the conditions of the assay.
Measzlrements of p18SerbB-2 Level's in Tumors
Radioimmunohistochemistry was directly compared with conventional immunohistochemistry using both frozen and paraffin sections in a series of 60 breast carcinomas.
Radioimmunohistochemistry. There was a bimodal distribution of c-erbB-2 expression in the tumors, with the larger group of lower expressors ranging from MCF-7 to MDA-MB-361 levels. A smaller group of tumors had much higher levels of receptors, ranging from BT474 levels to above N87 ( Figure 3A) .
Frozen Section Immunohistochemistry. Cell pellet sections yielded homogeneous staining, with membranes and cytoplasm labeled in all cells except for the MCF7s. which were entirely negative. The labeling was weak in z -7 5 -1 cells, with more label being detected in MDA-MB-453s. MDA-MB-361, BT474, SKBR3, and N87 cells were all strongly labeled. In the tumor sections the stroma was consistently clear, with benign breast elements giving weak signals. Staining throughout the tumor cells of an individual positive specimen was generally homogeneous, but a full range of expression levels was noted in the 60 breast cancer biopsies ( Figure 3B ). Both membrane and cytoplasmic staining was apparent in the positive cases. With the exception of occasional lymphoid cells exhibiting endogenous peroxidase activity, the control sections were clear. 
B
Paraffin Section Immunohistochemistry. Staining in MDA-MB-361, BT474, SKBR3, and N87 cells was strong in the cell membranes and cytoplasm. MDA-MB-453 cells were moderately labeled, with no evidence of any signal in MCF-7. In contrast to the frozen section data, ZR75-1 cells were also negative. In the tumors, staining was generally weaker than in frozen sections, with the majority of specimens falling into a negative category ( Figure 3C) . No signal was apparent in benign breast elements. In the positive tumor specimens the stroma was clear, with heterogeneous staining apparent in many cases. Both membrane and cytoplasmic staining were apparent, with control sections showing little background. The photomicrographs in Figure 4 illustrate the comparison between immunohistochemistry and radioimmunohistochemistry. 
RADIOIMMUNOHISTOCHEMISTRY
Comparisons Between Radioimmunohistochemistry and Paraflin and Frozen Section Conventionaj Immunohistochemistry
When the frozen section immunohistochemical histoxores are compared with the radioimmunohistochemical data (Figure 5A ). there is a defined relationship in the tumors expressing low to moderate levels of c-erbB-2 (rank correlation coefficient 0.81; p<O.OOS). In the 12 highly expressing cases this relationship breaks down (rank correlation coefficient -0.07; p =0.84). When the paraffin section histoscores are compared with the radioimmunohistochemical results ( Figure SB) in the low to moderately expressing tumors, it is clear that the paraffin section method is not sufficiently sensitive to detect the receptors in this group. In the highly expressing cases, the conventional method detects the receptors but there was a poor correlation between the histoscore and the radioimmunohistochemically-derived receptor content (rank correlation coefficient 0.039; p=0.91).
Discussion
This report introduces radioimmunohistochemistry as a method for quantifying p185erbB-2 in frozen tissue sections. The technique is compared directly with conventional immunohistochemistry using both frozen and paraffin-embedded tissue. Quantitation within the assay is dependent on the use of a panel of cell lines with a range of c-er6B-2 expression levels as internal calibration standards, and we have measured the receptor levels in these cells by antibody binding analysis. In addition, the relative proportions of receptors within the cells has been confirmed by dot-blot analysis using two independent antibodies. The vast majority of studies examining c-erbB-2 expression in tissue biopsy specimens have used conventional immunohistochemistry on paraffin-embedded material. In our hands, this method resulted in positivity in about 22% of the breast carcinoma biopsies ( Figure 3C ), which is consistent with previous reports (reviewed by Gullick, 1990) . Using conventional methods on frozen sections, we found that a far greater proportion (92%) of the tumors were positively labeled ( Figure 3B ). Radioimmunohistochemistry was sufficiently sensitive to measure the receptor levels in all but one of the 60 tumors ( Figure 3A) . When the three methods are compared directly, the shortfalls of the conventional methods are clear. When the paraffin section histoscores are compared with the radioimmunohistochemical receptor density estimations ( Figure 5B ), it can be seen that the paraffin section method is only sufficiently sensitive to detect the receptors in the most highly expressing tissues. Within this group there is a poor correlation between the histoscore and the receptor density, which may be a result of fixation artifacts. These limitations suggest that paraffin section immunohistochemistry for c-erbB-2 expression can be used only to assign the tumor specimens into two groups: those expressing none to moderate levels of receptors or those with a very high receptor density. Within the high group, the poor correlation between histoscore and receptor density indicates that the histoscore should not be used as a measure of relative receptor density. The precise cut-off point between the low and high groups is likely to be arbitrary and dependent on the method of tissue preparation and type of reagents. In frozen sections, conventional immunohistochemistry detects the receptors in the majority of tumors. There is a defined relationship between the histoscore and the radioimmunohistochemical receptor density estimation in the low to moderately expressing tumors, but not in the highest group (Figure 5A) .
The histoscore can, with caution, be used as a measure of relative receptor density. However, some tumors with similar histoscores have at least a fivefold difference in their receptor levels from radioimmunohistochemical analysis. Clearly, the histoscore cannot be used as a measure of relative receptor density in the highly expressing tumors in which the conventional method has reached saturation. With one exception, only those tumors with near-maximal histoscores in the frozen sections attained anything but the lowest scores in the paraffin sections (Figure 5C) . Concerns with the loss of antigenicity and variable staining with immunohistochemistry for the c-erbB-2 protein in formalin-fixed, paraffin-embedded tissues have been voiced since the early studies on this receptor, and frozen section immunohistochemistry has been shown to be more sensitive (Slamon et al., 1989) . Surprisingly, the vast majority of studies have continued to use fixed material for examination of c-erbB-2 expression in tissue biopsy specimens. In addition to the limitations of paraffin and frozen section immunohistochemistry outlined above, there are problems associated with poor standardization among laboratories and the subjective nature of assigning histoscores to immunohistochemical sections.
There is agreement between the relative ratios of receptors from binding analysis data and radioimmunohistochemistry in six of the seven cell lines. However, the highest c-erbB-2-expressing cell line (N87) appears to have fewer receptors from radioimmunohistochemical analysis than would be suggested from the binding studies. It was noted that the binding affinity of the antibody for the N87 receptors was lower than that calculated for the other cell lines, which may be a consequence of the very high receptor density within this line. The dot-blot studies using denatured protein indicate that N87 cells do not have a vastly higher receptor content than BT474s. suggesting that the binding analysis may have overestimated the receptor levels within N87s. These observations suggest that radioimmunohistochemical grain counts may not be directly proportional to c-erbB-2 levels in highly expressing tissues and cells. However, it is reasonable to suggest that the grain counts can be used for tissues within this category for rank correlation purposes.
Previous immunohistochemical studies looking at the relationship between c-erbB-2 expression and biological or clinical charac- teristics of human tumors have been confined to the arbitrary positive or negative cut-off levels governed by the techniques themselves. Indeed, most studies have used paraffin section immunohistochemistry, which does not have the sensitivity to detect this protein in some 70-80% of breast tumors. Without an investigation into the clinical relevance of the lower levels of c-erbB-2 expression, the full significance of this molecule may not have been realized. This is explored in a parallel clinical publication (Robertson et al., 1996) . The wide range of receptor densities quantifiable by radioimmunohistochemistry now enables determination of the most appropriate thresholds of expression, based on the biological and clinical characteristics of the tumors themselves rather than on the sensitivity of the methodology. This new method can be transferred among laboratories because the calculated receptor densities within the tumors are not dependent on the sensitivity of the technique or type of reagents. Instead, they are calculated from absolute standards in the form of internal calibration control cell lines. In addition, counting of the grain density by image analysis is objective. Because radioimmunohistochemistry requires substantial resources and is a technique that is more involved and time-consuming than conventional immunohistochemistry and also requires the handling and use of radioisotopes (albeit at very low levels), its use is more suited to the research rather than the routine setting. However, when absolute measurements of receptors within tissues are required the technique should be invaluable. With the present interest in receptor targeted imaging and therapy in tumors with high levels of ~1 8 5~'~~-* , an accurate method of receptor measurement in biopsies, such as radioimmunohistochemistry, is required for assessing the suitability of patients for treatment. The promise of radioimmunohistochemistry lies in the ease with which the method can be extended to other fields in which relevant monoclonal antibodies are available. Indeed, we have used a similar method for the measurement of epidermal growth factor receptors in tumor biopsies (Stanton et al., 1994; Hendler and Ozanne, 1984) and are extending the assay to measure levels of c-edB-3 expression.
